NCT01329406View on ClinicalTrials.gov

Study to Evaluate the Efficacy of Milnacipran in the Treatment of Pain Due to Osteoarthritis

PHASE4UnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

September 30, 2012

Conditions
Osteoarthritis
Interventions
DRUG

Milnacipran

1 tablet (100mg) by mouth twice daily for 28 days

DRUG

Placebo

1 tablet by mouth twice daily for 28 days

Trial Locations (1)

01760

RECRUITING

Analgesic Solutions, Natick

Sponsors

Collaborators (1)

Forest Laboratories
All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

Analgesic Solutions

INDUSTRY